Invention Application
- Patent Title: 2-(ARYL- OR HETEROARYL-)PHENYL (AZA)BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
-
Application No.: US15312022Application Date: 2015-05-19
-
Publication No.: US20170101416A1Publication Date: 2017-04-13
- Inventor: Tao WANG , Zhongxing Zhang , John F. Kadow
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee: BRISTOL-MYERS SQUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- International Application: PCT/US2015/031569 WO 20150519
- Main IPC: C07D491/048
- IPC: C07D491/048 ; C07D405/10
Abstract:
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV: formula (I).
Public/Granted literature
- US09840511B2 2-(aryl or heteroaryl-)phenyl (AZA)benzofuran compounds for the treatment of hepatitis C Public/Granted day:2017-12-12
Information query
